Pfizer To Make $54 Billion Off Treating COVID Over & Over (Jimmy Dore)

The pandemic has been disastrous, to say nothing of deadly, for the vast majority of us, but that doesn’t mean COVID-19 hasn’t represented a boon for certain sectors. Case in point: Pfizer, which is on pace to see more than $100 billion in additional revenue thanks to the COVID vaccine and Paxlovid, which together have more than doubled Pfizer’s sales figures since early 2020. And with no end to COVID-19 in sight, Pfizer is poised to keep on raking in the billions for treating, but never eradicating, what has turned out to be a very profitable virus for this Big Pharma enterprise.

Jimmy and America’s comedian Kurt Metzger discuss the windfall Pfizer has enjoyed thanks to this oft-mutating bugger of a virus.



It's impossible that the jabs will work after the virus changed. They were only ever designed to combat one aspect of the original strain, the spike protein. The virus spikes changed since at least the Delta Strain rendering the jabs ineffective, like an out of date influenza vaccine but worse. They cannot possibly work, and on top of that they are experimental and dangerous (going from the VAERS data and clinical information). 

[Posted at the SpookyWeather2 blog, August 4, 2022.]